Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Dec 21, 2023 (filed on Dec 26, 2023)Insider Name:Akkaraju SrinivasOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:904,977Price:$4.42
-
Dec 12, 2023 (filed on Dec 14, 2023)Insider Name:Roth DavidOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-6,287Price:$4.95
-
Dec 06, 2023 (filed on Dec 08, 2023)Insider Name:Roth DavidOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-6,287Price:$3.95
-
Dec 02, 2023 (filed on Dec 05, 2023)Insider Name:Chee ConleyOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:86,000Price:--
-
Dec 01, 2023 (filed on Dec 05, 2023)Insider Name:Simonian Nancy AOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:D - Disposition to issuer under Rule 16b-3(e)# or value acquired/disposed of:-30,399Price:--
-
Dec 01, 2023 (filed on Dec 05, 2023)Insider Name:Simonian Nancy AOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:D - Disposition to issuer under Rule 16b-3(e)# or value acquired/disposed of:-29,399Price:--
-
Dec 01, 2023 (filed on Dec 05, 2023)Insider Name:Simonian Nancy AOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:D - Disposition to issuer under Rule 16b-3(e)# or value acquired/disposed of:-28,001Price:--
-
Dec 01, 2023 (filed on Dec 05, 2023)Insider Name:Simonian Nancy AOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:D - Disposition to issuer under Rule 16b-3(e)# or value acquired/disposed of:-17,499Price:--
-
Dec 01, 2023 (filed on Dec 05, 2023)Insider Name:Simonian Nancy AOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:D - Disposition to issuer under Rule 16b-3(e)# or value acquired/disposed of:-7,500Price:--
-
Nov 01, 2023 (filed on Nov 02, 2023)Insider Name:Simonian Nancy AOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3# or value acquired/disposed of:-13,401Price:$2.22
Filings by filing date
-
Dec 21, 2023 (filed on Dec 26, 2023)Insider Name:Akkaraju SrinivasOwnership Type:Indirect OwnershipSecurities:Common StockNature of Transaction:P - Open market or private purchase# or value acquired/disposed of:904,977Price:$4.42
-
Dec 12, 2023 (filed on Dec 14, 2023)Insider Name:Roth DavidOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-6,287Price:$4.95
-
Dec 06, 2023 (filed on Dec 08, 2023)Insider Name:Roth DavidOwnership Type:Direct OwnershipSecurities:Common StockNature of Transaction:S - Open market or private sale# or value acquired/disposed of:-6,287Price:$3.95
-
Dec 02, 2023 (filed on Dec 05, 2023)Insider Name:Chee ConleyOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:86,000Price:--
-
Dec 01, 2023 (filed on Dec 05, 2023)Insider Name:Simonian Nancy AOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:D - Disposition to issuer under Rule 16b-3(e)# or value acquired/disposed of:-30,399Price:--
-
Dec 01, 2023 (filed on Dec 05, 2023)Insider Name:Simonian Nancy AOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:D - Disposition to issuer under Rule 16b-3(e)# or value acquired/disposed of:-29,399Price:--
-
Dec 01, 2023 (filed on Dec 05, 2023)Insider Name:Simonian Nancy AOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:D - Disposition to issuer under Rule 16b-3(e)# or value acquired/disposed of:-28,001Price:--
-
Dec 01, 2023 (filed on Dec 05, 2023)Insider Name:Simonian Nancy AOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:D - Disposition to issuer under Rule 16b-3(e)# or value acquired/disposed of:-17,499Price:--
-
Dec 01, 2023 (filed on Dec 05, 2023)Insider Name:Simonian Nancy AOwnership Type:Direct OwnershipSecurities:Stock Option (right to buy)Nature of Transaction:D - Disposition to issuer under Rule 16b-3(e)# or value acquired/disposed of:-7,500Price:--
-
Oct 31, 2023 (filed on Nov 02, 2023)Insider Name:Simonian Nancy AOwnership Type:Direct OwnershipSecurities:Restricted Stock UnitsNature of Transaction:M - Exercise or conversion exempt under rule 16b-3# or value acquired/disposed of:-40,125Price:--
News
Biz Brief
Sector: Healthcare | Industry: Biotechnology & Medical Research |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 35 Cambridge Park Drive CAMBRIDGE MA 02140 |
Tel: | N/A |
Website: | https://syros.com |
IR: | See website |
Key People | ||
Conley Chee President, Chief Executive Officer, Director | Jason Haas Chief Financial Officer | Gerald E. Quirk Chief Legal Officer |
David A. Roth Chief Medical Officer | Kristin Stephens Chief Development Officer |
Business Overview |
N/A |
Financial Overview |
For the nine months ended 30 September 2023, Syros Pharmaceuticals Inc revenues decreased 39% to $9.5M. Net loss increased 11% to $100.2M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects FV Adjustments of Financial Investments decrease from $12.5M (income) to $77K (expense), Research & Development - Balancing value increase of 7% to $60.8M (expense). |
Employees: | 117 as of Dec 31, 2022 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $78.71M as of Dec 31, 2023 |
Annual revenue (TTM): | $8.80M as of Dec 31, 2023 |
EBITDA (TTM): | -$132.82M as of Dec 31, 2023 |
Net annual income (TTM): | -$104.96M as of Dec 31, 2023 |
Free cash flow (TTM): | -$123.14M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 25,660,038 as of Dec 18, 2023 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |